Search hospitals > Virginia > Gloucester
Peninsula Cancer Institute-Gloucester
Claim this profileGloucester, Virginia 23061
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Parotid Gland Cancer
Conducts research for Colon Cancer
Conducts research for Ductal Carcinoma In Situ
25 reported clinical trials
6 medical researchers
Summary
Peninsula Cancer Institute-Gloucester is a medical facility located in Gloucester, Virginia. This center is recognized for care of Breast Cancer, Breast cancer, Parotid Gland Cancer, Colon Cancer, Ductal Carcinoma In Situ and other specialties. Peninsula Cancer Institute-Gloucester is involved with conducting 25 clinical trials across 46 conditions. There are 6 research doctors associated with this hospital, such as Khalid Matin, Erin R. Alesi, Jennifer L. Myers, and Asit K. Paul.Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER positive
ER negative
2Breast Cancer
HER2 positive
ER positive
ER negative
Top PIs
Khalid MatinVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
14 reported clinical trials
30 drugs studied
Erin R. AlesiVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Squamous Cell Carcinoma
14 reported clinical trials
20 drugs studied
Jennifer L. MyersVirginia Commonwealth University/Massey Cancer Center4 years of reported clinical research
Studies Parotid Gland Cancer
Studies Bile Duct Cancer
9 reported clinical trials
20 drugs studied
Asit K. PaulVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Bladder Cancer
9 reported clinical trials
26 drugs studied
Clinical Trials running at Peninsula Cancer Institute-Gloucester
Breast Cancer
Breast cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Lung Cancer
Cancer
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Peninsula Cancer Institute-Gloucester?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.